Subgroup A resembles proneural GBM and is enriched in the expression of MYC-pathway genes, whereas subgroup B resembles mesenchymal GBM and has the greater mutational burden and decreased DNA-repair gene expression. The gene discussed is MYC; the disease is glioblastoma.